India’s bioeconomy is on a remarkable trajectory, poised to reach approximately $200 billion by 2025, a significant leap from around $10 billion in 2014. This rapid growth is fueled by robust policy support, an upsurge in startup initiatives, and increased public investments, as highlighted by Union Minister Jitendra Singh during the 14th Foundation Day of the Biotechnology Industry Research Assistance Council (BIRAC).
Accelerated Growth of the Bioeconomy
Singh noted that the bioeconomy recorded an impressive annual growth rate of 17-18% over the past year, with its valuation climbing from about $165 billion to $195 billion. This growth positions India well on its path to achieving a target of $300 billion by 2030, underscoring the vital role biotechnology plays in sectors such as healthcare, agriculture, climate solutions, and sustainable manufacturing.
The BioE3 Policy: A Game Changer
At the forefront of this expansion is the BioE3 Policy—Biotechnology for Economy, Environment, and Employment. Singh emphasized that this initiative is crucial for bolstering bio-based industries and promoting sustainable biomanufacturing. The policy aims to drive innovation across various domains, including precision biotherapeutics, smart proteins, climate-resilient agriculture, bio-based chemicals, and carbon capture technologies.
Financial Support and Investment
Financial backing is pivotal for sustaining this growth. The government has established the Research, Development, and Innovation (RDI) Fund, boasting an outlay of ₹1 lakh crore. This fund is designed to channel long-term investments into biotechnology ventures and facilitate the scaling of groundbreaking technologies. Such support is anticipated to yield significant advancements in the industry.
Contributions to GDP and Startup Ecosystem
According to the India Bioeconomy Report (IBER) 2026, released during the event, the bioeconomy reached $195.3 billion in 2025, contributing approximately 4.8% to India’s GDP, with a compound annual growth rate nearing 18%. This sector has more than doubled since 2020 and is bolstered by a vibrant ecosystem of over 11,800 biotech startups across the nation.
Bridging Research and Industry
BIRAC has emerged as a crucial connector, facilitating the transition of scientific innovations from research environments to market-ready solutions. Through funding, incubation, and mentorship, the organization has played a vital role in nurturing these innovations, ensuring they benefit society and the economy.
Fostering Scientific Talent
Singh also highlighted the importance of nurturing scientific talent from diverse regions, including tier-2 and tier-3 cities. Targeted initiatives are being implemented to create a broader innovation ecosystem, ensuring that emerging talent contributes to India’s growing bioeconomy. This focus on inclusivity aims to tap into the rich potential of scientific minds across the country.
Conclusion
India’s bioeconomy is on the verge of a transformative milestone, driven by strategic policies and a flourishing startup landscape. As the sector continues to evolve, it holds the promise of significant contributions to the economy and societal well-being. The collaborative efforts of the government, industry, and academic institutions will be instrumental in realizing this vision.
- Takeaways:
- India’s bioeconomy is set to reach $200 billion by 2025, with a target of $300 billion by 2030.
- The BioE3 Policy aims to promote sustainable biomanufacturing and innovation.
- The RDI Fund of ₹1 lakh crore is pivotal for long-term biotech investments.
- The sector’s growth is driven by an expanding network of over 11,800 startups.
- Inclusivity in nurturing scientific talent is essential for sustaining innovation.
Read more → www.businessworld.in